The Biden administration‘s approval of a fourth mRNA COVID-19 shot for those 50 and older has raised eyebrows in political and medical circles.
The Food and Drug Administration authorized a second booster shot of the Pfizer-BioNTech and Moderna vaccines for older adults and people as young as 12 with certain immune deficiencies but did so without convening a meeting of its panel of vaccine experts first, a move that angered healthcare experts skeptical of a fourth shot’s utility.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.